At a glance (2022)
Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the research, diagnosis and treatment of allergies through the development and commercialisation of allergen immunotherapy (AIT) products and services.
![](/sites/default/files/annual-reports/2022/graph.jpg)
The Group’s extensive product portfolio, available in multiple formulations (subcutaneous, sublingual drops and tablets), offers patients innovative solutions to improve quality of life for people with allergies.
A world leader in allergen immunotherapy, Stallergenes Greer has an extensive global footprint and the largest allergen and finished AIT product manufacturing capacity globally.
1,102
employees worldwide
19
countries with a direct presence
41
countries with a distribution network